Scynexis (SCYX) Change in Intangibles (2021 - 2022)
Scynexis (SCYX) reported Change in Intangibles of $9000.0 for Q1 2022, down 95.5% on a YoY basis from $200000.0 in Q1 2021, and down 98.46% quarter-over-quarter from $583000.0 in Q4 2021.
Scynexis (SCYX) Change in Intangibles (2021 - 2022) Analysis & Trends
Scynexis has reported Change in Intangibles for 2 years, with the latest figure at $9000.0 in Q1 2022.
- For the quarter ending Q1 2022, Change in Intangibles fell 95.5% year-over-year to $9000.0; the trailing twelve-month figure through Dec 2022 stood at $9000.0 (down 99.23% YoY), and the FY2022 full-year result was $9000.0, down 99.23% from the prior year.
- Change in Intangibles for Q1 2022 stood at $9000.0, down from $583000.0 in the prior quarter.
- The five-year high for Change in Intangibles was $583000.0 in Q4 2021, with the low at $9000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 583,000.00 |
| Dec 31, 2021 | 583,000.00 |
| Sep 30, 2021 | 338,000.00 |
| Sep 30, 2021 | 338,000.00 |
| Jun 30, 2021 | 51,000.00 |
| Jun 30, 2021 | 51,000.00 |
| Mar 31, 2021 | 200,000.00 |
| Mar 31, 2021 | 200,000.00 |